| Dr Randolph Ken Shoup, DDS | |
|
14297 Bergen Blvd # 100, Noblesville, IN 46060-3358 | |
| (317) 776-1100 | |
| (317) 776-1129 |
| Full Name | Dr Randolph Ken Shoup |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 14297 Bergen Blvd # 100, Noblesville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295741577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 12008036A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Randolph Ken Shoup, DDS 14297 Bergen Blvd # 100, Noblesville, IN 46060-3358 Ph: (317) 776-1100 | Dr Randolph Ken Shoup, DDS 14297 Bergen Blvd # 100, Noblesville, IN 46060-3358 Ph: (317) 776-1100 |
News Archive
Los Alamos National Laboratory researcher Bette Korber is part of an international team of investigators working to design and implement the first human trial of a mosaic HIV vaccine candidate. The vaccine represents a novel strategy for fighting the virus that causes AIDS by attempting to address one of the most daunting challenges in HIV vaccine design: the virus's extensive genetic diversity.
With a $1.2 million grant from Fondation Botnar, an international team of researchers will assess the feasibility of creating and launching a global-scale artificial intelligence (AI) app for mobile devices that diagnoses diet-related problems and offers nutritional advice to adolescent girls living in urban settings in Ghana and Vietnam.
Based on data from a multi-site imaging trial involving more than 2,600 women, researchers say breast lesions categorized as 'probably benign' on supplemental screening ultrasound could be re-evaluated with imaging in 12 months, reducing patient anxiety, follow-up exams and unnecessary biopsies. Results of the study are published online in the journal Radiology.
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
› Verified 4 days ago
James Huseman, DDS Dentist Medicare: Medicare Enrolled Practice Location: 485 Noble Creek Dr, Noblesville, IN 46060 Phone: 131-777-0124 | |
Yidi Liu, DDS, MSD Dentist Medicare: Not Enrolled in Medicare Practice Location: 5594 E 146th St Ste 220, Noblesville, IN 46062 Phone: 765-613-0740 | |
Dr. Chad Owen Hazelrigg, D.D.S., M.S.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 106 Lakeview Drive, Noblesville, IN 46060 Phone: 317-773-3617 Fax: 317-773-2360 | |
Dr. Gregory B Hopkinson, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 14139 Town Center Blvd Ste 200, Noblesville, IN 46060 Phone: 317-773-9992 | |
Dr. Jeremy Adam Friedman, D.D.D Dentist Medicare: Medicare Enrolled Practice Location: 16000 Prosperity Dr, Suite 100, Noblesville, IN 46060 Phone: 317-703-1066 Fax: 317-703-1067 | |
Dr. Robin I Raub, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 19405 Little Chicago Rd, Noblesville, IN 46062 Phone: 317-773-3839 Fax: 317-773-4577 | |
Daniel A. Mcgrath, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 14780 North Pointe Blvd., Noblesville, IN 46060 Phone: 317-770-9730 Fax: 317-770-7690 |